The synergistic pharmacodynamics of Vitamin D3 and Vitamin K2: An exhaustive narrative review of evidence-based medicine on skeletal integrity, cardiovascular protection, and systemic calcium homeostasis
Nutrition and Health · 18.11.2026
DOI: 10.1177/02601060261507463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition and Health, online erschienen am 18.11.2026. Verfasst von Khaled M Hasan. Beteiligte Einrichtung: Department of Physician Assistant, School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, MD, USA. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
The co-supplementation of Vitamin D3 (cholecalciferol) and Vitamin K2 (menaquinone) represents a paradigm shift in nutritional pharmacology, moving toward a systems biology approach for regulating calcium homeostasis. Mechanistically, Vitamin D3 upregulates the expression of Vitamin K-dependent proteins—Osteocalcin and Matrix Gla Protein—while Vitamin K2 acts as the essential cofactor for their activation via gamma-carboxylation. This cascade directs calcium into the bone matrix and inhibits ectopic soft tissue calcification.
Aim
This review evaluates the synergistic pharmacodynamics and clinical efficacy of D3 and K2 co-supplementation in addressing the “Calcium Paradox,” where calcium is concurrently lost from the skeleton and deposited in arterial walls.
Methods
A narrative synthesis of relevant randomized-controlled trials and clinical literature was conducted to assess the impact of combined supplementation on bone turnover biomarkers, lumbar spine bone mineral density (BMD), and the progression of coronary artery calcification (CAC). Summary Evidence demonstrates that combined supplementation consistently reduces undercarboxylated osteocalcin levels and attenuates age-related BMD decline in postmenopausal populations. In the cardiovascular domain, the pivotal AVADEC trial indicates that while established aortic valve calcification may be refractory, co-supplementation significantly decelerates CAC progression in high-risk subjects. The analysis further highlights the pharmacokinetic advantages of the menaquinone-7 homolog over menaquinone-4 and emphasizes the critical safety contraindication for patients on Vitamin K antagonists like warfarin. Current evidence supports D3 and K2 co-supplementation as a robust, dual-action therapeutic strategy for optimizing skeletal integrity and vascular health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physician Assistant, School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, MD, USA.
ORCID-Profile: Khaled M Hasan
Zitieren
APA
Hasan, K. M. (2026). The synergistic pharmacodynamics of Vitamin D3 and Vitamin K2: An exhaustive narrative review of evidence-based medicine on skeletal integrity, cardiovascular protection, and systemic calcium homeostasis. Nutrition and Health. https://doi.org/10.1177/02601060261507463
Vancouver
Hasan KM. The synergistic pharmacodynamics of Vitamin D3 and Vitamin K2: An exhaustive narrative review of evidence-based medicine on skeletal integrity, cardiovascular protection, and systemic calcium homeostasis. Nutrition and Health. 2026. doi:10.1177/02601060261507463
BibTeX
@article{Hasan2026,
author = {Hasan, Khaled M},
title = {The synergistic pharmacodynamics of Vitamin D3 and Vitamin K2: An exhaustive narrative review of evidence-based medicine on skeletal integrity, cardiovascular protection, and systemic calcium homeostasis},
journal = {Nutrition and Health},
year = {2026},
doi = {10.1177/02601060261507463}
}
EUVIMED